| 8614332 |
Substituted pyrazolylamides useful as glucokinase activators |
Peter Cheng, Scott A. Bolton, Sean Chen, Yan Shi, Wei Meng +2 more |
2013-12-24 |
$398,872,000 |
| 8273777 |
Glucokinase activators and methods of using same |
Yan Shi, Peter Cheng, Ying Wang |
2012-09-25 |
$131,638,000 |
| 8263659 |
Thyroid receptor ligands |
Jon J. Hangeland, Todd J. Friends, Tamara Dejneka, Pratik Devasthale, Yolanda Caringal +4 more |
2012-09-11 |
$63,719,000 |
| 8153677 |
Substituted pyrazolylamide compounds useful as glucokinase activators |
Peter Cheng, Scott A. Bolton, Sean Chen, Yan Shi, Wei Meng +2 more |
2012-04-10 |
$232,277,000 |
| 7910747 |
Phosphonate and phosphinate pyrazolylamide glucokinase activators |
Peter Cheng, Scott A. Bolton, Sean Chen, Yan Shi, Wei Meng +1 more |
2011-03-22 |
$68,690,000 |
| 7812048 |
Glucokinase activators and methods of using same |
Yan Shi, Peter Cheng, Ying Wang |
2010-10-12 |
$75,310,000 |
| 7557143 |
Thyroid receptor ligands |
Jon J. Hangeland, Todd J. Friends, Tamara Dejneka, Pratik Devasthale, Yolanda Caringal +4 more |
2009-07-07 |
$85,729,000 |
| 7342127 |
Substituted anilide ligands for the thyroid receptor |
William N. Washburn, Wei Meng, Bruce A. Ellsworth, Thomas Ericsson, Mahmoud Rahimi-Ghadim +2 more |
2008-03-11 |
$59,494,000 |
| 7288571 |
Thyroid receptor ligands and method II |
Jon J. Hangeland, Minsheng Zhang, Yolanda Caringal, Yi Li, Johan Malm +5 more |
2007-10-30 |
$59,372,000 |
| 7153997 |
Benzamide derivatives as thyroid receptor ligands |
Neeraj Garg, Mahmoud Rahimi Ghadim, Thomas Ericsson, Lars Johan Malm |
2006-12-26 |
$32,435,000 |
| 7109164 |
Aniline-derived ligands for the thyroid receptor |
Todd J. Friends, Minsheng Zhang |
2006-09-19 |
$50,468,000 |
| 6989402 |
Thyroid receptor ligands and method II |
Jon J. Hangeland, Minsheng Zhang, Yolanda Caringal, Yi Li, Johan Malm +5 more |
2006-01-24 |
$38,538,000 |
| 6800605 |
Aniline-derived ligands for the thyroid receptor |
Todd J. Friends, Minsheng Zhang |
2004-10-05 |
$25,070,000 |
| 6395784 |
Benzamide ligands for the thyroid receptor |
— |
2002-05-28 |
$249,269,000 |
| 6117885 |
Biphenyl-substituted quinoline derivatives |
John Lloyd |
2000-09-12 |
$1,324,459,000 |
| 5770615 |
Catecholamine surrogates useful as .beta..sub.3 agonists |
Peter Cheng, Gregory S. Bisacchi, Ashvinikumar V. Gavai, Kathleen M. Poss, Philip M. Sher +2 more |
1998-06-23 |
$220,931,000 |
| 5635504 |
Diazepine containing dual action inhibitors |
Chong-Oing Sun |
1997-06-03 |
$144,236,000 |
| 5151513 |
N-heterocyclic alcohol derivatives |
Harold N. Weller, III |
1992-09-29 |
$50,042,000 |
| 5055466 |
N-morpholino derivatives and their use as anti-hypertensive agents |
Harold N. Weller, III |
1991-10-08 |
$41,680,000 |
| 4981843 |
N-heterocyclic alcohol derivatives |
Harold N. Weller, III |
1991-01-01 |
|
| 4885292 |
N-heterocyclic alcohol renin inhibitors |
Harold N. Weller, III |
1989-12-05 |
$32,347,000 |
| 4757050 |
Ureido renin inhibitors |
Sesha I. Natarajan, Edward W. Petrillo, Jr. |
1988-07-12 |
$13,101,000 |
| 4665193 |
Amino acid ester renin inhibitors |
Edward W. Petrillo, Jr. |
1987-05-12 |
$9,499,000 |
| 4629724 |
Amino acid ester and amide renin inhibitors |
Edward W. Petrillo, Jr. |
1986-12-16 |
$27,361,000 |
| 4616088 |
Amino acid ester and amide renin inhibitor |
Edward W. Petrillo, Jr. |
1986-10-07 |
$18,066,000 |
